A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers

Gynecologic Oncology

Volumn 134, Issue 3, 2014, Pages 492-497

  Cass, Ilana ^a,b   Walts, Ann E ^b   Barbuto, Denise ^b   Lester, Jenny ^a,b   Karlan, Beth ^a,b  

^a Samuel Oschin Comprehensive Cancer Institute   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

BRCA; Fallopian tube; p53 signature; Serous tubal intraepithelial carcinoma

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OCCULT CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SALPINGOOOPHORECTOMY; TUMOR SUPPRESSOR GENE; UTERINE TUBE CARCINOMA; BRCA; CYSTADENOCARCINOMA; GENETICS; MIDDLE AGED; MUTATION; P53 SIGNATURE; PATHOLOGY; PRECANCER; SEROUS TUBAL INTRAEPITHELIAL CARCINOMA; UTERINE TUBE; UTERINE TUBE TUMOR;

BRCA; FALLOPIAN TUBE; P53 SIGNATURE; SEROUS TUBAL INTRAEPITHELIAL CARCINOMA;

ADULT; AGED; CARCINOMA IN SITU; CYSTADENOCARCINOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 84908340204     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.07.084     Document Type: Article

References (37)

1. Perets, R., Wyant, G.A., Muto, K., Bijon, J.G., Poole, B.B., Chin, K.T., et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;TP53;Pten models. Cancer Cell 24 (2013), 751–765.
2. Crum, C.P., Drapkin, R., Miron, A., Ince, T.A., Muto, M., Kindelberger, D.W., et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19:1 (2007), 3–9.
3. Alvarado-Cabrero, I., Young, R., Vamvakas, E., Scully, R., Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 72 (1999), 367–379.
4. Kindelberger, D.W., Lee, Y., Miron, A., Hirsch, M.S., Feltmate, C., Medeiros, F., et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31:2 (2007), 161–169.
5. Colgan, T.J., Murphy, J., Cole, D.E., Narod, S., Rosen, B., Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol 25:10 (2001), 1283–1289.
6. Leeper, K., Garcia, R., Swisher, E., Greer, B., Paley, P., Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol 87:1 (2002), 52–56.
7. Carcangiu, M.L., Radice, P., Manoukian, S., Spatti, G., Gobbo, M., Pensotti, V., et al. Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers. Int J Gynecol Pathol 23 (2003), 35–40.
8. Powell, C.B., Kenley, E., Chen, L.M., Crawford, B., McLennan, J., Zaloudek, C., et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol 23:1 (2005), 127–132.
9. Medeiros, F., Muto, M., Lee, Y., Elvin, J.A., Callahan, M.J., Feltmate, C., et al. The tubal fimbria is a preferred site of early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30:2 (2006), 230–236.
10. Finch, A., Beiner, M., Lubinski, J., Lynch, H.T., Moller, P., Rosen, B., et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296:2 (2006), 185–192.
11. Callahan, M.J., Crum, C.P., Medeiros, F., Kindelberger, D.W., Elvin, J.A., Garber, J.E., et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25 (2007), 3985–3990.
12. Powell, C.B., Chen, L., McLennan, J., Crawford, B., Rabban, J.T., Moore, D.H., et al. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with consecutive series of 111 patients using a standardized surgical–pathological protocol. Int J Gynecol Cancer 21:5 (2011), 846–851.
13. Lee, Y., Miron, A., Drapkin, R., Nucci, M.R., Medeiros, F., Saleemuddin, A., et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211 (2007), 26–35.
14. Crum, C.P., Drapkin, R., Kindelberger, D., Medeiros, F., Miron, A., Lee, Y., Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous carcinomas. Clin Med Res 5 (2007), 35–44.
15. Karst, A.M., Levanon, K., Drapkin, R., Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc Natl Acad Sci 108 (2011), 7547–7552.
16. Kim, J., Coffey, D.M., Creighton, C.J., Yu, Z., Hawkins, S.M., Matzuk, M.M., High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci 109:10 (2012), 3921–3926.
17. Integrated genomic analysis of ovarian carcinoma. Cancer Genomic Atlas Research Network. Nature 474:7353 (2011), 609–615.
18. Shaw, P.A., Rouzbahman, M., Pizer, E.S., Pintilie, M., Begley, H., Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. Mod Pathol 22 (2009), 1133–1138.
19. Norquist, B.M., Garcia, R.L., Allison, K.H., Jokinen, C.H., Kernochan, L.E., Pizzi, C.C., et al. The molecular pathogenesis of hereditary ovarian carcinoma. Cancer 116 (2010), 5261–5271.
20. Roh, M.H., Yassin, Y., Miron, A., Mehra, K.K., Mehrad, M., Monte, N.M., et al. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN, and PAX2 expression. Mod Pathol 23 (2010), 1316–1324.
21. Mingels, M.J.J.M., Roelofsen, T., van der Laak, J., Hullu, J., van Ham, M., Massuger, L., et al. Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-carriers and controls. Gynecol Oncol 127:1 (2012), 88–93.
22. Yanai-Ibar, I., Silverberg, G., Mucosal epithelial proliferation of the fallopian tube: prevalence, clinical associations, and optimal strategy for histopathologic assessment. Int J Gynecol Pathol 19:2 (2000), 139–144.
23. Piek, J.M., van Diest, P.J., Zweemer, R.P., Jansen, J.W., Poort-Keesom, R.J., Menko, F.H., et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195:4 (2001), 451–456.
24. Visvanathan, K., Vang, R., Shaw, P., Gross, A., Soslow, R., Parkash, V., et al. Diagnosis of serous tubal intraepithelial carcinoma based upon morphologic immunohistochemical features: a reproducibility study. Am J Surg Pathol 35:12 (2011), 1766–1775.
25. Viscus, D., Shaw, P.A., Finch, A., Rosen, B., Murphy, J., Armel, S., et al. Risk factors for non-invasive lesions if the fallopian tube in BRCA mutation carriers. Gynecol Oncol 118 (2010), 295–298.
26. Folkins, A.K., Jarboe, E.A., Saleemuddin, A., Lee, Y., Callahan, M.J., Drapkin, R., et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol 109 (2008), 168–173.
27. Saleemuddin, A., Folkins, A.K., Garrett, L., Garber, J., Muto, M., Crum, C.P., et al. Risk factors for serous precursor cancer (“p53 signature”) in women with inherited BRCA mutations. Gynecol Oncol 111 (2008), 226–232.
28. Carlson, J.W., Jarbie, E.A., Kindelberger, D., Nucci, M.R., Hirscxh, M.S., Crum, C.P., Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol 29 (2010), 310–314.
29. Sonnedecker, H.E., Cooper, K., Kalian, K.N., Primary fallopian tube adenocarcinoma in situ with adjuvant therapy for breast carcinoma. Gynecol Oncol 52 (1994), 402–407.
30. Yanai-Inbar, I., Siriaunkgul, S., Silverberg, S.G., Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential?. Int J Gynecol Pathol 14:2 (1995), 107–113.
31. Cheung, A., Young, R., Scully, R., Pseudocarcinomatous hyperplasia of the fallopian tube associated with salpingitis: a report of 14 cases. Am J Surg Pathol 18:11 (1994), 1125–1130.
32. Gupta, S., Singh, P., Bala, J., Mushtaq, D., Goyal, A., Pseudocarcinomatous hyperplasia of the fallopian tubes which was associated with female genital tract tuberculosis, histologically mimicking tubal adenocarcinoma: a diagnostic challenge. J Clin Diagn Res 6:8 (2012), 1419–1421.
33. Greene, M., Piedmonte, M., Alberts, D., Gail, M., Hensley, M., Miner, Z., et al. A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study. Cancer Epidemiol Biomarkers Prev 17:3 (2008), 594–604.
34. Cass, I., Holschneider, C., Datta, N., Barbuto, D., Walts, A.E., Karlan, B.Y., BRCA-mutation-associated fallopian tube carcinoma. Obstet Gynecol 106:6 (2010), 1327–1334.
35. Morelli, M., Venturella, R., Mocciaro, R., Di Cello, A., Rania, E., Lico, D., et al. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol 129:3 (2013), 448–451.
36. Greene, M.H., Mai, P.L., Schwartz, P.E., Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?. Am J Obstet Gynecol 204 (2011), 19.e1–19.e6.
37. Kwon, J.S., Tinker, A., Pansegrau, G., McAlpine, J., Housty, M., McCullum, M., et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 121 (2013), 14–24.